Cargando…

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis

Genetic variants in transmembrane 6 superfamily member 2 (TM6SF2), such as E167K, are associated with atherosclerotic cardiovascular disease (ASCVD). Chronic inflammation and lipid-laden macrophage foam cell formation are the central pathogeneses in the development of atherosclerosis. This study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wenzhen, Liang, Wenying, Lu, Haocheng, Chang, Lin, Zhang, Jifeng, Chen, Y. Eugene, Guo, Yanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497156/ https://www.ncbi.nlm.nih.gov/pubmed/36139452 http://dx.doi.org/10.3390/cells11182877

Ejemplares similares

Type 2 diabetes sex-specific effects associated with E167K coding variant in TM6SF2
por: Fan, Yanbo, et al.
Publicado: (2021)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
por: Holmen, Oddgeir L., et al.
Publicado: (2014)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
por: Li, Zu-Yin, et al.
Publicado: (2022)

TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
por: Basyte-Bacevice, Viktorija, et al.
Publicado: (2019)

PRDM16 deficiency in vascular smooth muscle cells aggravates abdominal aortic aneurysm
por: Wang, Zhenguo, et al.
Publicado: (2023)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

KLF11 protects against abdominal aortic aneurysm through inhibition of endothelial cell dysfunction
por: Zhao, Guizhen, et al.
Publicado: (2021)

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017)

The Tm7sf2 Gene Deficiency Protects Mice against Endotoxin-Induced Acute Kidney Injury
por: Gatticchi, Leonardo, et al.
Publicado: (2015)

Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis
por: Tang, Shan, et al.
Publicado: (2019)

N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021)

The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant
por: Zhang, Xiaoyu, et al.
Publicado: (2018)

PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease
por: Lisboa, Quelson Coelho, et al.
Publicado: (2020)

TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
por: Luo, Fei, et al.
Publicado: (2021)

TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes
por: Ryu, Jihye, et al.
Publicado: (2017)

Targeting TM4SF1 exhibits therapeutic potential via inhibition of cancer stem cells
por: Chen, Guang, et al.
Publicado: (2022)

TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells
por: Kitajima, Hiroshi, et al.
Publicado: (2023)

The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients
por: Raia, Gamal Y. S., et al.
Publicado: (2022)

m(6)Am methyltransferase PCIF1 is essential for aggressiveness of gastric cancer cells by inhibiting TM9SF1 mRNA translation
por: Zhuo, Wei, et al.
Publicado: (2022)

TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease
por: Sanchez-Pulido, Luis, et al.
Publicado: (2014)

Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line
por: Pant, Asmita, et al.
Publicado: (2021)

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
por: Luo, Fei, et al.
Publicado: (2021)

Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2
por: Pott, Janne, et al.
Publicado: (2021)

TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6
por: Hou, Sicong, et al.
Publicado: (2022)

E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6
por: Du, Shuixian, et al.
Publicado: (2017)

Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
por: Li, Bo-Tao, et al.
Publicado: (2020)

TM4SF5-mediated protein-protein networks and tumorigenic roles
por: Lee, Jung Weon
Publicado: (2014)

The loss of Tm7sf gene accelerates skin papilloma formation in mice
por: Bellezza, I., et al.
Publicado: (2015)

Amino acid transporters as tetraspanin TM4SF5 binding partners
por: Jung, Jae Woo, et al.
Publicado: (2020)

Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer
por: Peng, Xing‐Chun, et al.
Publicado: (2018)

Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation
por: Luo, Yonghong, et al.
Publicado: (2021)

Liver-specific deletion of Mttp versus Tm6sf2 reveals distinct defects in stepwise VLDL assembly
por: Newberry, Elizabeth P., et al.
Publicado: (2021)

The additive effects of the TM6SF2 E167K and PNPLA3 I148M polymorphisms on lipid metabolism
por: Chen, Lizhen, et al.
Publicado: (2017)

Laminar Flow Attenuates Macrophage Migration Inhibitory Factor Expression in Endothelial Cells
por: Qiao, Congzhen, et al.
Publicado: (2018)

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo
por: Cao, Jia, et al.
Publicado: (2015)

TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth
por: Singhal, Megha, et al.
Publicado: (2019)

Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
por: Neele, Annette E., et al.
Publicado: (2021)

LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2
por: Li, Qian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gasv3tcqkh9dij042d027djgkr